| Term 
 | Definition 
 
        |        Mannitol Glycerin Urea (Isosorbide) |  | 
        |  | 
        
        | Term 
 
        | Osmotic Diuretics   MOA Effects |  | Definition 
 
        |   Loop of Henle: washout of NaCl & urea   Proximal tubule: osmotic effect interfere w/ ability of kidney to [ ] urine Effects: Expand extracellular fluid volume (including plasma) Increase excretion of Na+, K+, Ca2+, Mg2+,HCO3-, H2PO4- Increase renal blood flow Moderate diuresis (~5% FENa) |  | 
        |  | 
        
        | Term 
 
        | Osmotic Diuretics Toxicity/ ADR |  | Definition 
 
        |  Heart failure, pulmonary congestion Mannitol: cranial bleeding |  | 
        |  | 
        
        | Term 
 
        | Carbonic  Anhydrase Inhibitor   Agents |  | Definition 
 
        |   Acetazolamide Dichlorphenamide Methazolamide Dorzolamide,  brinzolamide (topical for glaucoma) |  | 
        |  | 
        
        | Term 
 
        |  Carbonic Anhydrase Inhibitors  Uses   |  | Definition 
 
        |  Glaucoma           Acute Mountain Sickness Prophylaxis and treatment Decreases CSF formation Decreases pH of CSF àincreased ventilation Alkalosis from increased H+ excretion (diuretics)  Urinary alkalinization             Absence seizures  ↑ excretion HCO3 , Na, K, H2PO4 diuresis moderate |  | 
        |  | 
        
        | Term 
 
        | Carbonic Anhydrase Inhibitor  Toxicities |  | Definition 
 
        |          Metabolic acidosis Stones Potassium wasting Contraindicated in hepatic cirrhosis (decreases NH4+ excretion)
 Hypersensitivity reactions   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |           Furosemide Bumetanide Torsemide Ethacrynic acid   Site: Thick Ascending Limb          Mechanism: Inhibit Na+-K+-2Cl-symporterrequires transport by organic anion transporter
 ↑ excretion of Na, K, H, Ca, Mg, Cl diuresis profound |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |          Acute pulmonary edema Hyperkalemia, hypercalcemia Congestive heart failure (venous capacitance) Acute renal failure Hypertension   |  | 
        |  | 
        
        | Term 
 
        | Loop Diuretics Pharmacokinetics |  | Definition 
 
        |  All: highly protein bound, tubular secretion  Furosemide: elimination by kidneys, t1/2 ~1hr  Bumetanide: hepatic and renal elimination , t1/2 ~1hr  Torsemide: hepatic and renal elimination , t1/2 ~3.5 hr  Ethacrynic acid: hepatic and renal elimination , t1/2 ~1hr
 |  | 
        |  | 
        
        | Term 
 
        | Loop Diuretics Toxicities/ ADR |  | Definition 
 
        |  Depletion of Na+, loss of ECF volume, circulatory collapse Hypokalemia, hypomagnesemia, hypocalcemia Increase LDL and triglycerides, decrease HDL(effect on lipids less than thiazides)
 Hyperglycemia, precipitate diabetes (less than thiazides)
 Hyperuricemia Ototoxicity (especially ethacrynic acid) Hypersenstivity: furosemide and bumetamide |  | 
        |  | 
        
        | Term 
 
        | Thiazides thiazide-like Diuretics Agents Site / MOA |  | Definition 
 
        | Chlorothiazide, Hydrochlorothiazide Chlorthalidone Indapamide Metolazone  ↑ excretion of Na, K, H, HCO3, Cl, H2PO4 Site: Distal convoluted tubule   Mechanism: Inhibit Na+-Cl-symporter requires transport by organic anion transporter
 |  | 
        |  | 
        
        | Term 
 
        | Thiazide Diuretics Uses & Toxicities/ ADR |  | Definition 
 
        |        Edema Hypertension  Toxicity/Adverse Effects: Hyperuricemia (chronic use) Hypokalemic metabolic alkalosis Hyponatremia Increased LDL, total cholesterol, triglycerides (tend to normalize w/ chronic use) Decreased insulin secretion, impaired glucose tolerance Hypersensitivity reactions (rare) Erectile dysfunction |  | 
        |  | 
        
        | Term 
 
        | K sparing: Mineralocorticoid Antagonists Agents Site / MOA |  | Definition 
 
        |           Spironolactone  Eplerenone    Site: late distsal tubule & collecting duct Antagonist for aldosterone rp ↑ excretion of Na, Cl ↓ excretions of K, H, Ca, Mg |  | 
        |  | 
        
        | Term 
 
        | K sparing Mineralocorticoid Antagonists Uses / Toxicities |  | Definition 
 
        |  in combination with loop or  
thiazide to maintain Plasma K+ Hyperaldosteronism Edema from hepatic cirrhosis    Toxicity/Adverse Effects:                 Hyperkalemia  Spironolactone: gynecomastia, impotence, decreased libido, hirsutism, etc. Spironolactone: diarrhea, gastritis, gastric bleeding, peptic ulcers (contraindication) Eplerenone: GI  Eplerenone: interaction with CYP3A4 inhibitors |  | 
        |  | 
        
        | Term 
 
        | K sparing Diuretics  ENaC Inhibitors Agents Site / MOA |  | Definition 
 
        |              Triamterene Amiloride Site: Late distal tubule and early collecting duct  Mechanism: Inhibit Epithelial Na+Channel (this prevents activation of K+ secretion)
 ↑ excretion of Na, Cl ↓ excretion of K, H, Ca, Mg Mild diuresis |  | 
        |  | 
        
        | Term 
 
        | K sparing Diuretics ENaC Inhibitors Uses   Toxicities / MOA |  | Definition 
 
        |  In combination with loop or thiazide to maintain plasma K+ Hypertension due to polymorphism of ENaC Cystic fibrosis: aerosol   Toxicity/Adverse Effects: Hyperkalemia: ACE Inhibitors, NSAIDs Triamterene: impaired glucose tolerance Both: CNS, GI, musculoskeletal effects |  | 
        |  | 
        
        | Term 
 
        | Antidiuretic Hormone Antagonist Agent/ site / MOA |  | Definition 
 
        |       Conivaptan Tolvaptan  
Site: Collecting duct Mechanism: Antagonize Antidiuretic Hormone (ADH, aka arginine vasopressin) at V2 receptor
 ↑ excretion of H2O ↑ Urine output ↓ urine osmolality |  | 
        |  | 
        
        | Term 
 
        | Antidiuretic Hormone Antagonist Uses / Toxicities / MOA |  | Definition 
 
        |                     Hyponatremia (hyper~ or euvolemic) Clinically significant SIADH, cirrhosis, heart failure (tolvaptan) Toxicity/Adverse Effects CYP3A4: use with strong inhibitors contraindicated Conivaptan: strong inhibitor of CYP3A4 Neurologic sequelae from rapid correction of sodium Dehydration, hypovolemia Hyperkalemia with K+ sparing drugs (tolvaptan) Hyperglycemia |  | 
        |  | 
        
        | Term 
 
        | RAS  4 ways to decrease the activity of AT II |  | Definition 
 
        |   (1) inhibit the release of renin (b-blockers) (2) inhibit the activity of renin (3) inhibit the formation of AT-II by ACE (4) block the AT1 receptors for AT-II. |  | 
        |  | 
        
        | Term 
 
        | Renin Inhibitor   Aliskiren |  | Definition 
 
        |   ¯ PVR and ¯ blood pressure                                           increase renal blood flow                                      ¯ secretion of aldosterone                                             preserve potassium ¯ stimulation of AT2 receptors                               Does not effect::                                           Angiotensin (1-7)                                           renin activity                                              kinins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Captopril (active form with an active metabolite) Enalapril (ester prodrug)/Enalaprilat (active metabolite) Lisinopril (active form is excreted) |  | 
        |  | 
        
        | Term 
 
        | Competitive AT 1 Antagonists ARBs   |  | Definition 
 
        |   Losartan,  Irbesartan,  Valsartan |  | 
        |  | 
        
        | Term 
 
        | Therapeutic Applications   RAS Drugs |  | Definition 
 
        |   Hypertension –do not trigger reflex tachycardia –very effective when combined with a diuretic –can be effective even with low renin   Congestive Heart Failure –improved hemodynamics –slows hypertrophy/remodeling –improved left ventricular systolic function   Myocardial Infarction –prevent excessive remodeling of cardiac tissue –begin immediately after an infarction   Slowing of diabetic nephropathy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   severe hypotension, including postural hypotension, in patients who are hypo-volemic, salt-depleted, or have CHF (especially with the first dose) hyperkalemia in patients with impaired renal function or when combined with potassium-sparing diuretics problems associated with kinins (ACE inhibitors only) –cough, angioedema fetopathic after first trimester of pregnancy can induce acute renal failure in a patient with bilateral renal artery stenosis |  | 
        |  | 
        
        | Term 
 
        | Two Major Systems that regulate Blood Pressure |  | Definition 
 
        | SNS Sympathatic Nervous System   RAS Renin Angiotensin System |  | 
        |  | 
        
        | Term 
 
        |   When the SNS is activated,  NE (the sympathetic neurotransmitter)  is released from sympathetic nerve terminals and  stimulates: |  | Definition 
 
        |   4beta1 receptors in the heart to                     increase HR and contractility 4beta1 receptors in the kidney to  activate the RAS 4alpha1 receptors in the vasculature to                         cause vasoconstriction (á TPR) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective (block beta1 and beta2 receptors)  propranolol,  timolol,  nadolol,  carteolol,  penbutalol  and pindolol “cardioselective” (block only beta1)  metoprolol,  atenolol,  acebutolol,  betaxolol,  bisoprolol and esmolol; (used i.v. only) intrinsic sympathomimetic activity (ISA; weak partial agonist activity) pindolol, penbutalol,  carteolol, acebutolol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   4Decrease CO by decreasing chronotropy and inotropy                                 (â HR and â SV) 4Inhibit the RAS by blocking renal beta1 receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | maculopapular rash due to captopril (free sulfhydryl); less common with pro-drug ACE inhibitors Fever Dry cough  results from inhibition of BK metabolism in the lung;  Angioedema (mediated by BK); can be fatal Hypotension (first-dose effect); especially in high renin patients Orthostatic (postural) hypotension (more common when used in combination with diuretic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Constipation Headache Dizziness Edema Fatigue Bradycardia (especially verapamil and diltiazem) AV block (especially verapamil) Contraindications: 4CHF (especially verapamil due to cardiac depressant effect; negative inotrope) 4SA or AV bradyarrhythmias (verapamil and Diltiazem) 4SA or AV tachyarrhythmias (nifedipine-like) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First-dose hypotension, especially in high renin patients and when given with diuretics (like ACE inhibitors) Contraindicated in pregnancy Better tolerated than ACE inhibitors due to preservation of the BK degredation pathway (ACE-mediated) 4  less cough 4less angioedema |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Two Drugs used for Hypertensive Crisis |  | Definition 
 
        | Fenoldopam  i.v. only A selective Dopamine DA1 agonist; dilates arterioles Causes renal vasodilation Also dilates mesenteric and cerebral vascular beds, and lowers BP Increases RBF while lowering BP unlike other vasodilators Most useful in patients with renal insufficiency   Diazoxide i.v. for hypertensive emergencies Potassium channel opener; dilates arterioles Produces reflex activation of SNS  (á HR and edema due to RAS activation) |  | 
        |  |